Takeda Didn’t Warn of Actos Cancer Risk, Lawyer Says

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, failed to warn doctors of the cancer risk associated with its Actos diabetes treatment, a lawyer said as the first of more than 3,000 lawsuits over the drug went to trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.